VAX-D | What is VAX

	Spinal Relief Centre of Canada 53 The Links Road, Suite 201 Toronto, Ontario Telephone: (416) 222•3475		Vertebral Axial Decompression Therapy Return to Spinal Relief Centre home page

VAX-D Studies and Publications

VAX-D: Published Credibility
The definitive reference textbook on The Practice of Minimally Invasive Spinal Techniques, published by The College of Physicians Publishing Division, has an editorial board that reads like the WHO’S WHO of orthopedic surgeons worldwide.

In Chapter 35 of the 2005 edition of this text, the summary concludes that “VAX-D should not be considered traction in the traditional sense but as decompression. VAX-D is the only non-invasive treatment that has been proven to decompress the disc; with other traction devices, there has been only indirect proof.”

Peer-Reviewed and Published in Respected Medical Journals:

Journal of Orthopedic & Sports Physical Therapy (Vol. 35, No.1,
January 2005)
Short and Long-term Outcomes Following Treatment with the VAX-D Protocol for Patients with Chronic, Activity-limiting Low Back Pain. P.F. Beattie, PT, PhD, OCS; R. Nelson, MS, PhD; L. Michener, PT, PhD; J. Cammaratta, BS, DC; J. Donelly.
OUTCOME: A sample of 118 patients with unfavorable prognosis due to chronic low back pain reported significant improvements in pain and activity limitation after VAX-D.

Journal of Neurological Research (Vol. 26, April 2004)
Efficacy of Vertebral Axial Decompression on Chronic Low Back Pain. Dr. Gustav Ramos, MD.
OUTCOME: This 144 patient study showed 76% achieved remission of pain. Except in emergent conditions, VAX-D should be used on all patients before surgery is undertaken.

Anesthesiology News, (Vol. 29, No. 3, March 2003)
VAX-D Reduces Chronic Discogenic Low Back Pain. Robert H. Odell, M.D., Ph.D., Daniel Boudreau, D.O.
OUTCOME: Four years after VAX-D treatment, patients show a sustained 86% reduction in pain; 91% of patients had resumed their normal activities.

Journal of Neurological Research (Vol. 23, No. 7, October 2001)
Dermatomal Somatosensory Evoked Potential Demonstration of Nerve Root Decompression after VAX-D Therapy. William Naguszewski, MD; Robert Naguszewski, MD; Earl Gose, PhD.
OUTCOME: Of the study group, 77% reported pain reduction with successful decompression of the nerve roots at multiple levels.

Journal of Neurological Research (Vol. 23, No. 7, October 2001)
A Prospective Randomized Controlled Study of VAX-D and TENS for the Treatment of Chronic Low Back Pain. Eugene Sherry, MD, FRACS; Peter Kitchener, MD, FRANZCR; Russell Smart, MB, ChB.
OUTCOME: VAX-D treatment obtained a statistically significant reduction in pain and improvement in functional outcome in patients with disc-related chronic low back pain. TENS treatment recorded 0% improvement, while VAX-D treatment yielded a success rate of 68.4%.

Canadian Journal of Clinical Medicine (Vol. 6, No. 1, January 1999)
An Overview of Vertebral Axial Decompression. Frank Tilaro, M.D.
OUTCOME: After VAX-D treatment, the average pain reduction in patients was 77%.

Journal of Neurological Research (Vol. 20, No. 3, April 1998)
Vertebral Axial Decompression Therapy for Pain Associated with Herniated or Degenerative Discs or Facet Syndrome: An Outcome Study. Earl Gose, PhD; William Naguszewski, MD; Robert Naguszewski, MD.
OUTCOME: In 778 cases, VAX-D achieved a success rate of 71%. The authors consider VAX-D to be a primary modality for low back pain for lumbar herniations, degenerative discs, facet arthropathy, and decreased spinal mobility.

Canadian Journal of Clinical Medicine (Vol. 5, No.1, January 1998)
The Effects of VAX-D on Sensory Nerve Dysfunction in Patients with Low Back Pain and Radiculopathy. Frank Tilaro, MD; Dennis Miscovich, MD.
OUTCOME: VAX-D is significantly capable of influencing sensory nerve dysfunction associated with a compressive radiculopathy. Complete remission was achieved by 64% of the study group. .

Journal of Neurosurgery (Vol. 81: No. 3, 1994)
Effects of Vertebral Axial Decompression on Intradiscal Pressure. Gustavo Ramos, MD; William Martin, MD.
OUTCOME: VAX-D creates a negative intradiscal pressure force as low as -160 mmHg.